Rising prescription drug spending is a major concern for policymakers in California. In the California Health Care Foundation’s 2023 Health Policy Survey, 20% of Californians reported that they did not fill a prescription due to cost, a figure that rises to 33% for individuals who earn less than 200% of the federal poverty level; 16% of Californians reported cutting pills in half or skipping doses to save money. Nationally, 20% of adults who take between one to three prescription drugs have difficulty affording their medications, a number that increases to 32% for individuals who take four or more medications. A December 2022 report from the California Department of Managed Health Care found that health plans in the state paid approximately $10.8 billion for prescription drugs in 2021. This represents $2.1 billion in additional spending compared to 2017, a 22% increase.
White Papers
Real World Evidence Solutions Market Trends & Prospects by Leading Players Analysis
The global Real World Evidence Solutions market research includes the current condition of the industry and prospective forecasts for the years 2022–2032.
Historical data are included in the corporate report. The study describes upstream and downstream company development, industry development, and significant organisations. The analysis takes fragmentation and different segmentations into account as well as makes a logical assumption based on economic projections from an informational standpoint.
The quantitative impact assessment serves as a resource that the company can resort to for financial and technical information now and into the year 2031.
Healthcare’s digital age: Insights on Telehealth potential, EMR automation and more + 3 case studies
This eBook introduces you to intelligent test automation and explains how AI can take healthcare software testing to the next level of efficiency, coverage, and performance. It concludes with four real-world use cases demonstrating how healthcare organizations of all sizes can benefit.
Unlock Patient-Level Social Determinants Of Health With IQVIA NLP
There is an increased focus on the social determinants of health (SDOH) that has led to organizations trying to better understand how these impact patient outcomes. These complex and nuanced features are poorly defined and rarely included in structured data. With artificial intelligence (AI) technologies such as IQVIA NLP (natural language processing), data can be found and normalized for use in health equity initiatives.
Optimized chronic care interventions lead to better outcomes, guarantee cost savings
Health plans know that high-risk patients with chronic diseases use more care and account for more costs. How can health plans simultaneously improve clinical outcomes, boost member satisfaction and lower costs? The answer: by optimizing interventions for patients with chronic diseases that lead members to the right care at the right time. Effective chronic care interventions improve outcomes, close gaps in care and achieve meaningful cost savings and ROI. In fact, there are interventions with guaranteed year-one cost savings. Learn about these interventions in the new whitepaper – The ROI of Virtual Health: How Better Outcomes Drive Cost Savings for Health Plans.
Real World Evidence [RWE] Solutions Market Size is to Reach US$ 78.83 bn by 2030, Grow at CAGR of 7.8% | Research by SNS Insider
Real-world evidence is clinical evidence produced from information about the usage and possible advantages and disadvantages of a medical product (RWE). It speaks of data created by routine clinical practise and observational data gathered outside of randomized controlled trials (RCTs). RWD uses observational data to generate knowledge, extrapolative outcomes, knowledge of illnesses, clinical tools, neglected patient requirements, the value offered to subpopulations by side effects, and patient socioeconomics. To guarantee that patients receive the best care possible, real-world data are also used to analyse the results of patients.
Social Determinants of Health Data: Survey Results on the Collection, Integration, and Use
The American Health Information Management Association (AHIMA), a global nonprofit association of health information (HI) professionals and a leading voice and authority in the health care industry, is dedicated to improving the collection of actionable Social Determinants of the Health (SDOH) data. As part of its mission to empower people to impact health, in 2020 AHIMA called upon then-President-Elect Biden to bolster the country’s health system through the increased collection and use of accurate, timely, and complete patient health information.1 Two years later, AHIMA continues to pursue and promote this goal by highlighting that more-comprehensive SDOH data can offer additional insights to help enrich clinical decision-making and improve health outcomes.
Healthcare Provider Value-Based Performance Management Market Research 2023-2030
The Healthcare Provider Value-Based Performance Management Market report highlights an all-inclusive assessment of the revenue generated by the various segments across different regions for the forecast period, 2023 to 2030. To leverage business owners, and gain a thorough understanding of the current momentum, the Healthcare Provider Value-Based Performance Management Market research taps hard-to-find data on aspects including but not limited to demand and supply, distribution channel, and technology upgrades. Principally, the determination of strict government policies and regulations and government initiatives building the growth of the Healthcare Provider Value-Based Performance Management market offers knowledge of what is in store for business owners in the upcoming years.
Real World Evidence Solutions Market Size 2023 Research Report by Growth Factors, Major Challenges, PEST Analysis and Forecast to 2026
Worldwide “Real World Evidence Solutions Market” 2023 report offers business strategy, covers complete scenario for market definition and overview including market segmentation (type, application) and market exchange rate. Furthermore, this report give information on Market Competition Analysis by Market Performance, Product and Service Analysis, Strategies for Company to Deal with the Impact of COVID-19, market size, share, Sales, Value, Price and Gross Margin. The Real World Evidence Solutions market report offers a full data about the position, extent of development, and possibilities of players on the viewpoint with forecast year 2026.
Next Generation Patient Engagement & Enriched Insights
Over the last decade, PGHD and its value have become more widely recognized across clinical research and development, public health, and care delivery. Evidation has written a white paper that takes a closer look at the challenges of PGHD, its value to clinical decision makers, and how to contextualize it to optimize its value.
